• Users Online: 57
  • Print this page
  • Email this page
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
   Table of Contents - Current issue
Coverpage
July-September 2022
Volume 1 | Issue 3
Page Nos. 67-104

Online since Friday, September 30, 2022

Accessed 2,911 times.

PDF access policy
Journal allows immediate open access to content in HTML + PDF
View as eBookView issue as eBook
Access StatisticsIssue statistics
RSS FeedRSS
Hide all abstracts  Show selected abstracts  Export selected to  Add to my list
EDITORIAL  

Cardiovascular diseases guideline-directed medical therapy in low- and middle-income countries: A call for action p. 67
Hisham A Badreldin, Suliman Alghnam
DOI:10.4103/sjcp.sjcp_17_22  
[HTML Full text]  [PDF]  [Sword Plugin for Repository]Beta
ORIGINAL ARTICLE Top

Efficacy and predictors to response of octreotide and midodrine combination in patients with hepatorenal syndrome p. 69
Zinah Alabdulkarim, Dalal Alkortas, Mohammed Ibrahim Alsebayel, Faisal Aba Alkhail, Hussien Elsiesy, Ahmed Al-Jedai
DOI:10.4103/sjcp.sjcp_4_22  
Background: Hepatorenal syndrome (HRS) is a functional form of acute kidney injury (AKI) that develops in patients with advanced liver disease. The use of octreotide (OCT) and midodrine (MID) along with albumin is commonly used in practice despite lack of strong evidence. Objective: The purpose of the study is to evaluate the efficacy of combining octreotide and midodrine in HRS patients. Materials and Methods: This is a retrospective, single center study. All patients who received both OCT/MID from January 2005 to April 2013 were identified from the electronic pharmacy system at a major tertiary care center in Riyadh, Saudi Arabia. The aim of the study is to evaluate the safety and efficacy and predictors to response of the combination of OCT/MID in patients with decompensated liver cirrhosis with type I HRS receiving standard of care therapy. The primary endpoint was the change in estimated glomerular filtration rate (eGFR) within 30 days of starting therapy compared to baseline. Results: There was no significant improvement in eGFR using Cockcroft-Gault (CG) from baseline until the end of treatment (P = 0.311). Conclusion: Combination therapy of octreotide and midodrine along with albumin did not improve the eGFR in patients with type 1 HRS.
[ABSTRACT]  [HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta
CASE REPORT Top

Clinical course of a case of elizabethkingia meningoseptica in a critical neonate at a tertiary care hospital in Saudi Arabia p. 75
Faisal Aqeel AlSehli, Nawaf Sami Alsaeed, AlAnoud TofailAhmed Rajah, Saif AlSaif
DOI:10.4103/sjcp.sjcp_11_22  
Case Report: In this paper we discuss the clinical course of a 25-week gestational age preterm neonate who suffered with multiple comorbidities atop of an E. meningoseptica infection causing meningitis and hydrocephalus. A multitude of antibiotics were administered to the child, such as vancomycin, ciprofloxacin, trimethoprim-sulfamethoxazole, and rifampicin. However, the pathogen either had prior resistance to the agents or newly developed resistance along the disease course. After many trials of antibiotics, the usage of ceftazidime/avibactam and moxifloxacin dual therapy induced clinical and microbiological eradication of the pathogen. Objective: This case report aims to discuss the multidrug approach used to treat a preterm neonates Elizabethkingia Meningoseptica infection in a Tertiary Care Hospital in Saudi Arabia. Conclusion: E. meningoseptica is an uncommon infectious agent which can cause meningitis and even sepsis that is difficult to treat due to its multidrug resistance phenotype. Continuous reviews of new case reports on successful attempts of treating E. meningoseptica are paramount to maintaining updated therapy options for newly encountered cases in day-to-day practice in the neonatal intensive care unit (NICU).
[ABSTRACT]  [HTML Full text]  [PDF]  [Sword Plugin for Repository]Beta
ABSTRACTS Top

The 2nd International Annual Conference of the SSCP Accepted Abstract: Clinical Pharmacy; Healthcare Professionals Theme p. 79

DOI:10.4103/WKMP-0249.357710  
[HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta

The 2nd International Annual Conference of the SSCP Accepted Abstract: Clinical Pharmacy; Students Theme p. 87

DOI:10.4103/WKMP-0249.357711  
[HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta

The 2nd International Annual Conference of the SSCP Accepted Abstract: Pharmacotherapy; Healthcare Professionals p. 96

DOI:10.4103/WKMP-0249.357712  
[HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta

The 2nd International Annual Conference of the SSCP Accepted Abstract: Pharmacotherapy; Students Theme p. 102

DOI:10.4103/WKMP-0249.357713  
[HTML Full text]  [PDF]  [Mobile Full text]  [EPub]  [Sword Plugin for Repository]Beta